Exponent (EXPO) Stock Forecast, Price & News

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Exponent in the last twelve months. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" EXPO shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in EXPO, but not buy additional shares or sell existing shares.
View EXPO analyst ratings or view top-rated stocks.

3 analysts have issued twelve-month price targets for Exponent's stock. Their EXPO share price forecasts range from $99.00 to $110.00. On average, they anticipate the company's share price to reach $104.50 in the next twelve months. This suggests a possible upside of 22.7% from the stock's current price.
View analysts price targets for EXPO or view top-rated stocks among Wall Street analysts.

Exponent's stock was trading at $99.09 on January 1st, 2023. Since then, EXPO shares have decreased by 14.0% and is now trading at $85.18.
View the best growth stocks for 2023 here.

Exponent saw a increase in short interest during the month of September. As of September 15th, there was short interest totaling 1,170,000 shares, an increase of 10.4% from the August 31st total of 1,060,000 shares. Based on an average daily volume of 212,200 shares, the days-to-cover ratio is presently 5.5 days. Currently, 2.3% of the shares of the company are sold short.
View Exponent's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, October 26th 2023.
View our EXPO earnings forecast.

Exponent, Inc. (NASDAQ:EXPO) released its earnings results on Thursday, July, 27th. The business services provider reported $0.50 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.51 by $0.01. The business services provider earned $129.65 million during the quarter, compared to the consensus estimate of $130.40 million. Exponent had a net margin of 19.03% and a trailing twelve-month return on equity of 30.41%. The business's revenue for the quarter was up 9.7% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.49 earnings per share.

Exponent declared a quarterly dividend on Tuesday, July 25th. Investors of record on Friday, September 8th will be paid a dividend of $0.26 per share on Friday, September 22nd. This represents a $1.04 annualized dividend and a yield of 1.22%. The ex-dividend date of this dividend is Thursday, September 7th.
Read our dividend analysis for EXPO.

ETFs with the largest weight of Exponent (NASDAQ:EXPO) stock in their portfolio include iShares Emergent Food and AgTech Multisector ETF (IVEG), Argent Mid Cap ETF (AMID), Hypatia Women Ceo ETF (WCEO), Pacer Lunt MidCap Multi-Factor Alternator ETF (PAMC), ALPS O'Shares U.S. Small-Cap Quality Dividend ETF (OUSM), Franklin U.S. Small Cap Multifactor Index ETF (FLQS), Vident Core U.S. Equity Fund (VUSE) and iShares Russell 2000 Growth ETF (IWO).

Exponent (NASDAQ:EXPO) pays an annual dividend of $1.04 per share and currently has a dividend yield of 1.22%. The company has been increasing its dividend for 5 consecutive years, indicating the company has a new, but growing committment to grow its dividend. The dividend payout ratio is 52.79%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, EXPO will have a dividend payout ratio of 46.43% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for EXPO.

Exponent's stock split before market open on Thursday, June 7th 2018. The 2-1 split was announced on Tuesday, May 15th 2018. The newly minted shares were payable to shareholders after the market closes on Wednesday, June 6th 2018. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

15 employees have rated Exponent Chief Executive Officer Catherine Corrigan on Glassdoor.com. Catherine Corrigan has an approval rating of 84% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Exponent investors own include AbbVie (ABBV), Pfizer (PFE), Abbott Laboratories (ABT), Energy Transfer (ET), Ford Motor (F), Micron Technology (MU), AT&T (T), UnitedHealth Group (UNH), Visa (V) and Adobe (ADBE).

Exponent trades on the NASDAQ under the ticker symbol "EXPO."

Shares of EXPO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of EXPO stock can currently be purchased for approximately $85.18.

Exponent (NASDAQ:EXPO) has a market capitalization of $4.33 billion and generates $513.29 million in revenue each year. The business services provider earns $102.33 million in net income (profit) each year or $1.97 on an earnings per share basis.

The company employs 1,313 workers across the globe.

Exponent's mailing address is 149 COMMONWEALTH DRIVE, MENLO PARK CA, 94025. The official website for the company is www.exponent.com. The business services provider can be reached via phone at (650) 326-9400, via email at investor-relations@exponent.com, or via fax at 650-326-8072.